Radiotherapy Market Latest Trends and Business Scenario 2030

Radiotherapy Market To Cross $17,194.4 million by 2030

© Prescient & Strategic Intelligence Private Limited. All rights reserved

1

The global radiotherapy market was valued at $7,222.4 million in 2019. As per the estimates of P&S Intelligence, a market research firm based in India, the market would progress at a CAGR of 8.4% between 2020 and 2030 and generate a revenue of $17,194.4 million in 2030. The increasing prevalence of cancer and the growing requirement for advanced treatment procedures all over the world are the key factors fueling the expansion of the market.

Receive Sample Copy of this Report: https://www.psmarketresearch.com/marketanalysis/radiotherapy-market-revenue/report-sample Rapid advancements in therapies and treatment procedures have generated a huge requirement for automated products that can be easily integrated into clinical practice systems, thereby making therapies more effective and quicker than they were before. Moreover, these technological advancements are pushing up the global demand for highly effective patient care. Furthermore, the availability of automated, efficient, and advanced clinical tools in radiation treatment and the emergence of highly accurate forms of radiotherapy are propelling the market advancement.

© Prescient & Strategic Intelligence Private Limited. All rights reserved

2

Make an Enquiry before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiryurl=radiotherapy-market-revenue Brachytherapy, IMRT, volumetric modulated arc therapy [VMAT], image-guided radiation therapy [IGRT]), stereotactic radiosurgery [SRS], SBRT, and proton therapy are some of the extremely accurate forms of radiotherapy. Besides this factor, the rising incidence of cancer across the world is also driving the progress of the radiotherapy market. As per the American Institute of Cancer Research, the total number of new cancer cases will reach nearly 25 million by 2030.

The institute also estimates that the low- and middle-income countries (LMICs) such as India and China will witness the highest prevalence of cancer in the coming years. Cancer is one of the major chronic diseases affecting people in several countries and augmenting the burden on healthcare systems in both developing and developed nations. According to the findings of the World Health Organization (WHO), cancer was responsible for the deaths of as many as 9.6 million people in 2018.

© Prescient & Strategic Intelligence Private Limited. All rights reserved

3

Report Description: https://www.psmarketresearch.com/market-analysis/radiotherapy-marketrevenue Based on type, the radiotherapy market is divided into internal beam, systematic, and external beam. Amongst these, the external beam category will register the highest growth in the market in the future. This is a very commonly used radiation therapy, in which, large parts of the body can be easily treated with the help of radiation from a machine placed outside the body. The increasing prevalence of cancer and the soaring research activities are fueling the growth of this category.

Globally, the North American radiotherapy market would be the most lucrative one in the forthcoming years. In this region, the market would exhibit the highest growth in the U.S. in the coming years, mainly because of the large-scale installation of radiotherapy equipment and systems in the country. In addition to this, the existence of several research institutes and private healthcare providing organizations that are extensively using radiotherapy systems is boosting the market advancement in the country.

Thus, it is quite clear from the above paragraphs that the market would demonstrate huge expansion all over the world in the years to come, primarily because of the rising prevalence of cancer and other chronic diseases and the ballooning requirement for advanced treatment procedures in various countries around the world.

© Prescient & Strategic Intelligence Private Limited. All rights reserved

4

MARKET SEGMENTATION The research offers market size of the global radiotherapy market for the period 2014–2030.

Market Segmentation by Type •

External Beam ➢ By product ▪

Linear accelerators (LINACs)

▪

Particle/proton therapy systems

▪

Conventional cobalt-60 teletherapy systems

➢ By technology

•

▪

Stereotactic therapy

▪

Image-guided

▪

Intensity-modulated

▪

Particle beam therapy

▪

3D conformal

Internal Beam ➢ By product ▪

Seeds

▪

Electronic brachytherapy systems

▪

Afterloaders

▪

Applicators

➢ By technology

•

▪

High-dose rate (HDR)

▪

Low-dose rate (LDR)

▪

Pulsed-dose rate (PDR)

Systemic

Market Segmentation by End User •

Hospitals

•

Independent Radiotherapy Centers

•

Cancer Research Institutes

© Prescient & Strategic Intelligence Private Limited. All rights reserved

5

Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications.

All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners.

An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd.

Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 ©P&SIntelligence.Allrightsreserved © Prescient & Strategic Intelligence Private Limited. All rights reserved

4 6